We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Conygar Investment Company | AQSE:CIC.GB | Aquis Stock Exchange | Ordinary Share | GB0033698720 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 58.00 | 68.00 | 67.00 | 63.00 | 63.00 | 39,160 | 15:29:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCIC
RNS Number : 8011Z
Conygar Investment Company PLC(The)
18 May 2023
18(th) May 2023
THE CONYGAR INVESTMENT COMPANY PLC
Planning approved for bioscience development
at The Island Quarter, Nottingham
The Conygar Investment Company PLC ("Conygar") is pleased to announce that Nottingham City Council has approved its detailed application for the next phase of The Island Quarter development in Nottingham. The application comprises a 23,123 sq.m. (249,000 sq.ft.) bioscience building, which includes both laboratory and office space. The permission is subject to the documenting of the section 106 agreement.
Robert Ware, Chief Executive of Conygar, commented:
"We are delighted that the next phase of development has been approved. Nottingham is already home to a large number of exciting businesses in the bioscience space and this scheme will be an excellent addition to the mixed-use development we are creating at The Island Quarter".
Enquiries:
The Conygar Investment Company PLC
Robert Ware: 020 7258 8670
Liberum Capital Limited (Nominated Adviser and Broker)
Richard Lindley: 020 3100 2185
Temple Bar Advisory (Public Relations)
Alex Child-Villiers: 07795 425580
William Barker: 07827 960151
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCKDLFFXELXBBV
(END) Dow Jones Newswires
May 18, 2023 02:00 ET (06:00 GMT)
1 Year Conygar Investment Chart |
1 Month Conygar Investment Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions